Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants.

Sarikas A, Carrier L, Schenke C, Doll D, Flavigny J, Lindenberg KS, Eschenhagen T, Zolk O.

Cardiovasc Res. 2005 Apr 1;66(1):33-44.

PMID:
15769446
2.

COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.

Flavigny J, Souchet M, Sébillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L.

J Mol Biol. 1999 Nov 26;294(2):443-56.

PMID:
10610770
3.

Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.

Bahrudin U, Morisaki H, Morisaki T, Ninomiya H, Higaki K, Nanba E, Igawa O, Takashima S, Mizuta E, Miake J, Yamamoto Y, Shirayoshi Y, Kitakaze M, Carrier L, Hisatome I.

J Mol Biol. 2008 Dec 26;384(4):896-907. doi: 10.1016/j.jmb.2008.09.070. Epub 2008 Oct 7.

PMID:
18929575
4.

Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathy.

Flavigny J, Robert P, Camelin JC, Schwartz K, Carrier L, Berrebi-Bertrand I.

Cardiovasc Res. 2003 Nov 1;60(2):388-96.

PMID:
14613868
5.

Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.

Mearini G, Gedicke C, Schlossarek S, Witt CC, Krämer E, Cao P, Gomes MD, Lecker SH, Labeit S, Willis MS, Eschenhagen T, Carrier L.

Cardiovasc Res. 2010 Jan 15;85(2):357-66. doi: 10.1093/cvr/cvp348. Epub 2009 Oct 22.

6.

Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice.

Vignier N, Schlossarek S, Fraysse B, Mearini G, Krämer E, Pointu H, Mougenot N, Guiard J, Reimer R, Hohenberg H, Schwartz K, Vernet M, Eschenhagen T, Carrier L.

Circ Res. 2009 Jul 31;105(3):239-48. doi: 10.1161/CIRCRESAHA.109.201251. Epub 2009 Jul 9.

7.

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities.

Schlossarek S, Mearini G, Carrier L.

J Mol Cell Cardiol. 2011 Apr;50(4):613-20. doi: 10.1016/j.yjmcc.2011.01.014. Epub 2011 Feb 1. Review.

PMID:
21291890
8.

Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy.

Schlossarek S, Englmann DR, Sultan KR, Sauer M, Eschenhagen T, Carrier L.

Basic Res Cardiol. 2012 Jan;107(1):235. doi: 10.1007/s00395-011-0235-3. Epub 2011 Dec 22.

PMID:
22189562
9.

Impairment of ubiquitin-proteasome system by E334K cMyBPC modifies channel proteins, leading to electrophysiological dysfunction.

Bahrudin U, Morikawa K, Takeuchi A, Kurata Y, Miake J, Mizuta E, Adachi K, Higaki K, Yamamoto Y, Shirayoshi Y, Yoshida A, Kato M, Yamamoto K, Nanba E, Morisaki H, Morisaki T, Matsuoka S, Ninomiya H, Hisatome I.

J Mol Biol. 2011 Nov 4;413(4):857-78. doi: 10.1016/j.jmb.2011.09.006. Epub 2011 Sep 12.

PMID:
21939669
10.

Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.

van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, Schlossarek S, Carrier L, ten Cate FJ, Stienen GJ, van der Velden J.

Circulation. 2009 Mar 24;119(11):1473-83. doi: 10.1161/CIRCULATIONAHA.108.838672. Epub 2009 Mar 9.

11.

Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice.

Cazorla O, Szilagyi S, Vignier N, Salazar G, Krämer E, Vassort G, Carrier L, Lacampagne A.

Cardiovasc Res. 2006 Feb 1;69(2):370-80. Epub 2005 Dec 27.

PMID:
16380103
12.

Expression of cardiac myosin-binding protein-C (cMyBP-C) in Drosophila as a model for the study of human cardiomyopathies.

Vu Manh TP, Mokrane M, Georgenthum E, Flavigny J, Carrier L, Sémériva M, Piovant M, Röder L.

Hum Mol Genet. 2005 Jan 1;14(1):7-17. Epub 2004 Nov 3.

PMID:
15525659
13.

The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy.

Vosberg HP.

Cardiovasc Res. 2005 Apr 1;66(1):1-3. No abstract available.

PMID:
15769440
14.

A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.

Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S.

J Biol Chem. 2015 Feb 27;290(9):5855-67. doi: 10.1074/jbc.M114.607911. Epub 2015 Jan 12.

15.

Comparison of two murine models of familial hypertrophic cardiomyopathy.

McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG.

Circ Res. 2001 Mar 2;88(4):383-9.

17.

Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes.

Pohlmann L, Kröger I, Vignier N, Schlossarek S, Krämer E, Coirault C, Sultan KR, El-Armouche A, Winegrad S, Eschenhagen T, Carrier L.

Circ Res. 2007 Oct 26;101(9):928-38. Epub 2007 Sep 6.

18.

Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.

Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kübler W, Katus HA.

J Clin Invest. 1997 Jul 15;100(2):475-82.

19.

The E3 ubiquitin ligase Asb2β is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.

Thottakara T, Friedrich FW, Reischmann S, Braumann S, Schlossarek S, Krämer E, Juhr D, Schlüter H, van der Velden J, Münch J, Patten M, Eschenhagen T, Moog-Lutz C, Carrier L.

J Mol Cell Cardiol. 2015 Oct;87:214-24. doi: 10.1016/j.yjmcc.2015.08.020. Epub 2015 Sep 3.

PMID:
26343497
20.

Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.

Carrier L, Bonne G, Bährend E, Yu B, Richard P, Niel F, Hainque B, Cruaud C, Gary F, Labeit S, Bouhour JB, Dubourg O, Desnos M, Hagège AA, Trent RJ, Komajda M, Fiszman M, Schwartz K.

Circ Res. 1997 Mar;80(3):427-34.

PMID:
9048664

Supplemental Content

Support Center